| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-60761-863-8_3 |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/978-1-60761-863-8_3 |
| P698 | PubMed publication ID | 20931388 |
| P2093 | author name string | Zhiguo Wang | |
| P2860 | cites work | MicroRNAs as targets for antisense-based therapeutics | Q37032639 |
| MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
| MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas | Q40073679 | ||
| MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation | Q41166615 | ||
| Computational methods for microRNA target prediction. | Q51907240 | ||
| Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing | Q24537549 | ||
| Sequence-specific inhibition of small RNA function | Q24797869 | ||
| Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
| Journal of molecular medicine | Q27717790 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells | Q28256740 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4 | Q28576826 | ||
| MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
| miR-21-mediated tumor growth | Q29616149 | ||
| MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
| Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. | Q34673364 | ||
| A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference | Q34919422 | ||
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 43-49 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | The principles of MiRNA-masking antisense oligonucleotides technology | |
| The Principles of MiRNA-Masking Antisense Oligonucleotides Technology | |||
| P478 | volume | 676 |
| Q98386176 | Advances in oligonucleotide drug delivery |
| Q52640764 | Anti-miRNA oligonucleotides: A comprehensive guide for design. |
| Q92920974 | Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model |
| Q26829583 | Clinical application of microRNA in gastric cancer in Eastern Asian area |
| Q38771880 | Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches |
| Q36500050 | Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D |
| Q35912379 | ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium |
| Q38113431 | Managing microRNAs with vector-encoded decoy-type inhibitors |
| Q64899756 | MicroRNA based theranostics for brain cancer: basic principles. |
| Q35543468 | MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart |
| Q28116103 | MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation |
| Q52673452 | MicroRNA-Based Drugs for Brain Tumors. |
| Q64041638 | MicroRNAs and Long Non-coding RNAs in Genetic Diseases |
| Q38271026 | MicroRNAs and atrial fibrillation: mechanisms and translational potential |
| Q37893954 | MicroRNAs in acute leukemia: from biological players to clinical contributors |
| Q38001790 | MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy |
| Q90743959 | Nuclear and Cytoplasmatic Quantification of Unconjugated, Label-Free Locked Nucleic Acid Oligonucleotides |
| Q26744362 | Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer |
| Q49593669 | Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis |
| Q92594523 | Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction |
| Q30833902 | Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells. |
| Q36992190 | Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). |
| Q36518163 | The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation |
| Q37912078 | The therapeutic potential of microRNAs: disease modulators and drug targets. |
| Q38092617 | miRNA-Based Therapeutic Strategies |
| Q38648154 | microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases |
Search more.